Disc Medicine(IRON) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update WATERTOWN, Mass. (May 9, 2024) – Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today reported financial results for the first quarter ended March 31, 2024. "The topline data from AURORA, presented in April, strengthened our belief that bito ...